CalciMedica
CALC
21 hedge funds and large institutions have $11.8M invested in CalciMedica in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
5% more funds holding
Funds holding: 20 → 21 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5.38% less ownership
Funds ownership: 33.05% → 27.67% (-5.4%)
20% less capital invested
Capital invested by funds: $14.8M → $11.8M (-$2.99M)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.21M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
+$112K |
| 3 |
JGC
J. Goldman & Co
New York
|
+$95.2K |
| 4 |
TW
TritonPoint Wealth
Chevy Chase,
Maryland
|
+$76.2K |
| 5 |
BlackRock
New York
|
+$66.7K |
Top Sellers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.17M |
| 2 |
O
OrbiMed
New York
|
-$1.24M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$312K |
| 4 |
Millennium Management
New York
|
-$22.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.35K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| – | -$229 | -55 | Closed |
|
CALC Hedge Fund Activity: Q2 2024 in Review
21 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q2 2024, worth a combined $11.8M — down 20% from $14.8M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new CALC positions and 5 closed out — a net gain of 1 holder — while 3 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.21M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $2.17M sold.
- 21 institutional investors held CalciMedica (CALC) as of Q2 2024, up from 20 in Q1 2024.
- Funds reported $11.8M of CalciMedica stock for Q2 2024, down 20% quarter-over-quarter.
- 6 funds opened new CalciMedica positions in Q2 2024 and 5 closed out, a net change of +1 holder.
- The largest CalciMedica buyer in Q2 2024 was Vanguard Group, an estimated $1.21M added.
- The largest CalciMedica seller in Q2 2024 was Stonepine Capital Management, an estimated $2.17M sold.
Based on aggregated 13F filings for Q2 2024.